| Detected | Trial | Change |
|---|---|---|
| 2026-08-16 | NCT05436223 Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory… |
overall status: Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05594797 | Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM | Multiple Myeloma | Recruiting |
| Phase 1 | |||
| NCT07647744 | To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects… | Renal Cell Carcinoma (RCC) | Recruiting |
| Early Phase 1 | |||
| NCT06045091 | To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for… | Multiple Myeloma | Recruiting |
| NCT06760260 | Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT05302648 | To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for… | Multiple Myeloma | Active, Not Recruiting |
| NCT05651178 | Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System… | Central Nervous System Lymphoma | Active, Not Recruiting |